{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:25:31Z","timestamp":1789097131896,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["P13-0171"],"award-info":[{"award-number":["P13-0171"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-02027"],"award-info":[{"award-number":["2019-02027"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-02724"],"award-info":[{"award-number":["2023-02724"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0064142"],"award-info":[{"award-number":["0064142"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["201602877"],"award-info":[{"award-number":["201602877"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20180244"],"award-info":[{"award-number":["20180244"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20200621"],"award-info":[{"award-number":["20200621"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20180247"],"award-info":[{"award-number":["20180247"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20200520"],"award-info":[{"award-number":["20200520"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20240094"],"award-info":[{"award-number":["20240094"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20241083"],"award-info":[{"award-number":["20241083"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20210466"],"award-info":[{"award-number":["20210466"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005848","name":"Henry Luce Foundation","doi-asserted-by":"publisher","award":["20230357"],"award-info":[{"award-number":["20230357"]}],"id":[{"id":"10.13039\/100005848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.vph.2025.107490","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:48:21Z","timestamp":1742053701000},"page":"107490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["PCSK6 ablation in blood circulating cells increases atherosclerotic burden, but improves plaque stability by activating Th17-smooth muscle cell modulatory axis"],"prefix":"10.1016","volume":"159","author":[{"given":"Bianca E.","family":"Suur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glykeria","family":"Karadimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.J.M.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Lengquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Kronqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Malin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Gister\u00e5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran K.","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"M\u00e4larstig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Hedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.J.","family":"Ketelhuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica","family":"Matic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vph.2025.107490_bb0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.vph.2025.107490_bb0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10170","key":"10.1016\/j.vph.2025.107490_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","year":"2019","journal-title":"Lancet"},{"issue":"10118","key":"10.1016\/j.vph.2025.107490_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.vph.2025.107490_bb0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.vph.2025.107490_bb0030","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/ATVBAHA.113.301743","article-title":"Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis","volume":"33","author":"Perisic","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.vph.2025.107490_bb0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.119.316063","article-title":"PCSK6 is a key protease in the control of smooth muscle cell function in vascular remodeling","volume":"126","author":"Rykaczewska","year":"2020","journal-title":"Circ. Res."},{"issue":"20","key":"10.1016\/j.vph.2025.107490_bb0040","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/CIRCULATIONAHA.119.044914","article-title":"Secretome analysis of cardiomyocytes identifies PCSK6 (Proprotein convertase Subtilisin\/Kexin type 6) as a novel player in cardiac remodeling after myocardial infarction","volume":"141","author":"Kuhn","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.vph.2025.107490_bb0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2025.107490_bb0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vph.2025.107490_bb0055","series-title":"SPC4\/PACE4 Regulates a TGF\u03b2 Signaling Network during axis Formation","author":"Constam","year":"2000"},{"issue":"6","key":"10.1016\/j.vph.2025.107490_bb0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/annrheumdis-2011-200300","article-title":"A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype","volume":"71","author":"Malfait","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.vph.2025.107490_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11070411","article-title":"Disruption of GPR35 signaling in bone marrow-derived cells does not influence vascular inflammation and atherosclerosis in Hyperlipidemic mice","volume":"11","author":"Baumgartner","year":"2021","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.vph.2025.107490_bb0070","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/CIRCRESAHA.115.306427","article-title":"Adaptive response of T and B cells in atherosclerosis","volume":"118","author":"Ketelhuth","year":"2016","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.vph.2025.107490_bb0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"6917","key":"10.1016\/j.vph.2025.107490_bb0080","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vph.2025.107490_bb0085","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1074\/jbc.M112.386573","article-title":"Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation","volume":"288","author":"Braun","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.vph.2025.107490_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.0801986","article-title":"TGF-beta promotes Th17 cell development through inhibition of SOCS3","volume":"183","author":"Qin","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.vph.2025.107490_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092062","article-title":"Role of cytokines, chemokines and IFN-gamma(+) IL-17(+) double-positive CD4(+) T cells in patients with multiple sclerosis","volume":"10","author":"Dias de Sousa","year":"2022","journal-title":"Biomedicines"},{"issue":"7357","key":"10.1016\/j.vph.2025.107490_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10228","article-title":"Control of TH17 cells occurs in the small intestine","volume":"475","author":"Esplugues","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vph.2025.107490_bb0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41419-024-07267-4","article-title":"Inhibition of furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities","volume":"15","author":"Ziane-Chaouche","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.vph.2025.107490_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1189\/jlb.2A0514-257RR","article-title":"Proprotein convertase FURIN regulates T cell receptor-induced transactivation","volume":"98","author":"Ortutay","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.vph.2025.107490_bb0115","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.188.6.1105","article-title":"Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin","volume":"188","author":"Gil-Torregrosa","year":"1998","journal-title":"J. Exp. Med."},{"issue":"7347","key":"10.1016\/j.vph.2025.107490_bb0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vph.2025.107490_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2013.11.021","article-title":"Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo","volume":"40","author":"Lim","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.vph.2025.107490_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.vph.2025.107490_bb0135","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/ajt.13350","article-title":"Hyperlipidemia promotes anti-donor Th17 responses that accelerate allograft rejection","volume":"15","author":"Yuan","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.vph.2025.107490_bb0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s44161-023-00295-x","article-title":"Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis increasing the risk of cerebrovascular complications","volume":"2","author":"Dib","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.vph.2025.107490_bb0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.vph.2025.107490_bb0150","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.vph.2025.107490_bb0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.07.152","article-title":"Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice","volume":"388","author":"van Es","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.vph.2025.107490_bb0160","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.vph.2025.107490_bb0165","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.vph.2025.107490_bb0170","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2025.107490_bb0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/cmi.2013.4","article-title":"Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice","volume":"10","author":"Ma","year":"2013","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.vph.2025.107490_bb0180","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.vph.2025.107490_bb0185","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"issue":"196","key":"10.1016\/j.vph.2025.107490_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006133","article-title":"Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway","volume":"5","author":"Gistera","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.vph.2025.107490_bb0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)63970-3","article-title":"Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme","volume":"158","author":"Dubois","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.vph.2025.107490_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1245266","article-title":"T-cell-expressed proprotein convertase FURIN inhibits DMBA\/TPA-induced skin cancer development","volume":"5","author":"Vahatupa","year":"2016","journal-title":"Oncoimmunology"},{"issue":"7060","key":"10.1016\/j.vph.2025.107490_bb0205","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nature04001","article-title":"Apolipoprotein-mediated pathways of lipid antigen presentation","volume":"437","author":"van den Elzen","year":"2005","journal-title":"Nature"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:08:09Z","timestamp":1762549689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189125000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":41,"alternative-id":["S1537189125000291"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107490","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK6 ablation in blood circulating cells increases atherosclerotic burden, but improves plaque stability by activating Th17-smooth muscle cell modulatory axis","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107490"}}